These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 11023138)

  • 41. Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart.
    Vague P; Selam JL; Skeie S; De Leeuw I; Elte JW; Haahr H; Kristensen A; Draeger E
    Diabetes Care; 2003 Mar; 26(3):590-6. PubMed ID: 12610006
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group.
    Holleman F; Schmitt H; Rottiers R; Rees A; Symanowski S; Anderson JH
    Diabetes Care; 1997 Dec; 20(12):1827-32. PubMed ID: 9405901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High prevalence of impaired awareness of hypoglycemia and severe hypoglycemia among people with insulin-treated type 2 diabetes: The Dutch Diabetes Pearl Cohort.
    van Meijel LA; de Vegt F; Abbink EJ; Rutters F; Schram MT; van der Klauw MM; Wolffenbuttel BHR; Siegelaar S; DeVries JH; Sijbrands EJG; Özcan B; de Valk HW; Silvius B; Schaper N; Stehouwer CDA; Elders PJM; Tack CJ; de Galan BE
    BMJ Open Diabetes Res Care; 2020 Feb; 8(1):. PubMed ID: 32107264
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sustained Reduction in Severe Hypoglycemia in Adults With Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia: Two-Year Follow-up in the HypoCOMPaSS Randomized Clinical Trial.
    Little SA; Speight J; Leelarathna L; Walkinshaw E; Tan HK; Bowes A; Lubina-Solomon A; Chadwick TJ; Stocken DD; Brennand C; Marshall SM; Wood R; Kerr D; Flanagan D; Heller SR; Evans ML; Shaw JAM
    Diabetes Care; 2018 Aug; 41(8):1600-1607. PubMed ID: 29661916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Additional lunchtime basal insulin during insulin lispro intensive therapy in a randomized, multicenter, crossover study in adults : a real-life design.
    Stades AM; Hoekstra JB; van den Tweel I; Erkelens DW; Holleman F;
    Diabetes Care; 2002 Apr; 25(4):712-7. PubMed ID: 11919130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beneficial effects of continuous subcutaneous insulin infusion in older patients with long-standing type 1 diabetes.
    Rizvi AA; Petry R; Arnold MB; Chakraborty M
    Endocr Pract; 2001; 7(5):364-9. PubMed ID: 11585372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Severe hypoglycemia in children and adolescents with IDDM: frequency and associated factors.
    Limbert C; Schwingshandl J; Haas J; Roth R; Borkenstein M
    J Diabetes Complications; 1993; 7(4):216-20. PubMed ID: 8219364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy.
    Fulcher GR; Gilbert RE; Yue DK
    Intern Med J; 2005 Sep; 35(9):536-42. PubMed ID: 16105155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Budget impact of continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes who experience severe recurrent hypoglycemic episodes in Spain.
    Giménez M; Elías I; Álvarez M; Quirós C; Conget I
    Endocrinol Diabetes Nutr; 2017; 64(7):377-383. PubMed ID: 28745609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes.
    Beato-Víbora P; Yeoh E; Rogers H; Hopkins D; Amiel SA; Choudhary P
    Diabet Med; 2015 Nov; 32(11):1453-9. PubMed ID: 26213236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prediction of severe hypoglycemia.
    Cox DJ; Gonder-Frederick L; Ritterband L; Clarke W; Kovatchev BP
    Diabetes Care; 2007 Jun; 30(6):1370-3. PubMed ID: 17363757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intensified insulin therapy and the risk of severe hypoglycaemia.
    Bott S; Bott U; Berger M; Mühlhauser I
    Diabetologia; 1997 Aug; 40(8):926-32. PubMed ID: 9267987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Counterregulation during spontaneous nocturnal hypoglycemia in prepubertal children with type 1 diabetes.
    Matyka KA; Crowne EC; Havel PJ; Macdonald IA; Matthews D; Dunger DB
    Diabetes Care; 1999 Jul; 22(7):1144-50. PubMed ID: 10388980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Durable reversal of hypoglycemia unawareness in type 1 diabetes.
    Dagogo-Jack S; Fanelli CG; Cryer PE
    Diabetes Care; 1999 May; 22(5):866-7. PubMed ID: 10332708
    [No Abstract]   [Full Text] [Related]  

  • 55. Functional intensified insulin therapy with short-acting insulin analog: effects on HbA1c and frequency of severe hypoglycemia. An observational cohort study.
    Hartemann-Heurtier A; Sachon C; Masseboeuf N; Corset E; Grimaldi A
    Diabetes Metab; 2003 Feb; 29(1):53-7. PubMed ID: 12629448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes.
    Choudhary P; Ramasamy S; Green L; Gallen G; Pender S; Brackenridge A; Amiel SA; Pickup JC
    Diabetes Care; 2013 Dec; 36(12):4160-2. PubMed ID: 24103902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Symptoms of acute insulin-induced hypoglycemia in humans with and without IDDM. Factor-analysis approach.
    Hepburn DA; Deary IJ; Frier BM; Patrick AW; Quinn JD; Fisher BM
    Diabetes Care; 1991 Nov; 14(11):949-57. PubMed ID: 1797507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metaanalysis of the effects of intensive glycemic control on late complications of type I diabetes mellitus.
    Wang PH; Lau J; Chalmers TC
    Online J Curr Clin Trials; 1993 May; Doc No 60():[5023 words; 37 paragraphs]. PubMed ID: 8306007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
    Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.